Status:
COMPLETED
A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to test the safety and effectiveness of MK-6213 as compared to MK-6213/Atorvastatin in participants 18 to 75 years) with high cholesterol.
Eligibility Criteria
Inclusion
- 18 to 75 years of age at the time of the study with high cholesterol
- Can have diabetes mellitus but is not currently on lipid lowering therapy
- Have a stable weight for \>6 weeks
Exclusion
- Has significant cardiovascular (heart), renal (kidney), neurologic (nervous system), respiratory (lung), hepatic (liver) or metabolic disease
- history of mental instability or drug/alcohol abuse within the past 5 years
- Pregnant or nursing; human immunodeficiency virus (HIV) positive; history of cancer within the past 5 years or participation in an investigational trial within the last 30 days
Key Trial Info
Start Date :
June 14 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2009
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT00687271
Start Date
June 14 2008
End Date
January 8 2009
Last Update
January 14 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.